U.S. Cell Banking Outsourcing Market Size, Share & Trends Analysis Report By Type (Master Cell Banking, Working Cell Banking, Viral cell Banking), By Cell Type (Stem Cell, Non-stem Cell), By Phase, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Type
                          1.2.2. Cell type
                          1.2.3. Phase
                          1.2.4. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in Italy
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                          1.7.3. Volume price analysis (Model 2)
                          1.7.4. Approach 2: Volume price analysis
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Type
                          2.2.2. Cell type
                          2.2.3. Phase
                      2.3. Competitive Insights
Chapter 3. Cell Banking Outsourcing Market Variables, Trends, & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                      3.3. Market Driver Analysis
                      3.4. Market Restraint Analysis
                          3.4.1. Industry Analysis - Porter’s Five Forces
                              3.4.1.1. Supplier power
                              3.4.1.2. Buyer power
                              3.4.1.3. Substitution threat
                              3.4.1.4. Threat of new entrant
                              3.4.1.5. Competitive rivalry
                          3.4.2. PESTEL Analysis
                              3.4.2.1. Political landscape
                              3.4.2.2. Technological landscape
                              3.4.2.3. Economic landscape
Chapter 4. U.S. Cell Banking Outsourcing Market Type Estimates & Trend Analysis
                      4.1. U.S. Cell Banking Outsourcing Market Type Dashboard
                      4.2. U.S. Cell Banking Outsourcing Market Type Movement Analysis
                      4.3. U.S. Cell Banking Outsourcing Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      4.4. Master Cell Banking
                          4.4.1. Master Cell Banking Market, 2018 - 2030 (USD Million)
                      4.5. Working Cell Banking
                          4.5.1. Working Cell Banking Market, 2018 - 2030 (USD Million)
                      4.6. Viral Cell Banking
                          4.6.1. Viral Cell Banking Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Cell Banking Outsourcing Market: Cell Type Estimates & Trend Analysis
                      5.1. U.S. Cell Banking Outsourcing Market Cell Type Dashboard
                      5.2. U.S. Cell Banking Outsourcing Market Cell Type Movement Analysis
                      5.3. U.S. Cell Banking Outsourcing Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      5.4. Stem Cell
                          5.4.1. Stem Cell Market, 2018 - 2030 (USD Million)
                      5.5. Cord Cell Banking
                          5.5.1. Cord Cell Banking Market, 2018 - 2030 (USD Million)
                      5.6. Embryonic Stem Cell Banking
                          5.6.1. Embryonic Stem Cell Banking Market, 2018 - 2030 (USD Million)
                      5.7. Adult Stem Cell Banking
                          5.7.1. Adult Stem Cell Banking Market, 2018 - 2030 (USD Million)
                      5.8. Dental Stem Cell Banking
                          5.8.1. Dental Stem Cell Banking Market, 2018 - 2030 (USD Million)
                      5.9. IPS Stem Cell Banking
                          5.9.1. IPS Stem Cell Banking Market, 2018 - 2030 (USD
                      5.10. Non-Stem Cell Banking
                          5.10.1. Non-Stem Cell Market, 2018 - 2030 (USD Million)
Chapter 6. U.S.Cell Banking Outsourcing Market: Phase Outlook Estimates & Trend Analysis
                      6.1. U.S. Cell Banking Outsourcing Phase Model Dashboard
                      6.2. U.S. Cell Banking Outsourcing Market Phase Movement Analysis
                      6.3. Cell Banking Outsourcing: Business Model Outlook Movement Analysis
                          6.3.1. Bank Storage Market, 2018 - 2030 (USD Million)
                          6.3.2. Master Cell Bank Preparation
                              6.3.2.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
                          6.3.3. Working Cell Bank Preparation
                              6.3.3.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)
                          6.3.4. Cell Storage Stability Testing
                              6.3.4.1. Cell Storage Stability Testing Market, 2018 - 2030 (USD Million)
                          6.3.5. Bank Characterization & Testing
                              6.3.5.1. Bank Characterization & Testing Market, 2018 - 2030 (USD Million)
                          6.3.6. Safety Testing
                              6.3.6.1. Safety Testing Market, 2018 - 2030 (USD Million)
                          6.3.7. Viral Cell Banks
                              6.3.7.1. Viral Cell Banks Market, 2018 - 2030 (USD Million)
                          6.3.8. Microbial Cell Banks
                              6.3.8.1. Microbial Cell Banks Market, 2018 - 2030 (USD Million)
                          6.3.9. Gene Expression Testing
                              6.3.9.1. Gene Expression Testing Market, 2018 - 2030 (USD Million)
                          6.3.10. Karyology Testing
                              6.3.10.1. Karyology Testing Market, 2018 - 2030 (USD Million)
                          6.3.11. Gene Sequencing Testing
                              6.3.11.1. Gene Sequencing Testing Market, 2018 - 2030 (USD Million)
                          6.3.12. Bank Preparation
                              6.3.12.1. Bank Preparation Market, 2018 - 2030 (USD Million)
                          6.3.13. Master Cell Bank Preparation
                              6.3.13.1. Master Cell Bank Preparation Market, 2018 - 2030 (USD Million)
                          6.3.14. Working Cell Bank Preparation
                              6.3.14.1. Working Cell Bank Preparation Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                      7.1. Recent Developments & Impact Analysis, By Key Market Participants
                      7.2. Company/Competition Categorization
                      7.3. Vendor Landscape
                          7.3.1. List of key distributors and channel partners
                          7.3.2. Key customers
                          7.3.3. Key company market share analysis, 2023
                          7.3.4. Cerner Corporation
                          7.3.5. Aldevron
                              7.3.5.1. Company overview
                              7.3.5.2. Financial performance
                              7.3.5.3. Product benchmarking
                              7.3.5.4. Strategic initiatives
                          7.3.6. Charles River Laboratories
                              7.3.6.1. Company overview
                              7.3.6.2. Financial performance
                              7.3.6.3. Product benchmarking
                              7.3.6.4. Strategic initiatives
                          7.3.7. Akron Biotech
                              7.3.7.1. Company overview
                              7.3.7.2. Financial performance
                              7.3.7.3. Product benchmarking
                              7.3.7.4. Strategic initiatives
                          7.3.8. VGXI, Inc
                              7.3.8.1. Company overview
                              7.3.8.2. Financial performance
                              7.3.8.3. Product benchmarking
                              7.3.8.4. Strategic initiatives
                          7.3.9. Catalent, Inc
                              7.3.9.1. Company overview
                              7.3.9.2. Financial performance
                              7.3.9.3. Product benchmarking
                              7.3.9.4. Strategic initiatives
                          7.3.10. DH Life Sciences, LLC
                              7.3.10.1. Company overview
                              7.3.10.2. Financial performance
                              7.3.10.3. Product benchmarking
                              7.3.10.4. Strategic initiatives
                          7.3.11. Recipharm AB
                              7.3.11.1. Company overview
                              7.3.11.2. Financial performance
                              7.3.11.3. Product benchmarking
                              7.3.11.4. Strategic initiatives
                          7.3.12. TriLink BioTechnologies
                              7.3.12.1. Company overview
                              7.3.12.2. Financial performance
                              7.3.12.3. Product benchmarking
                              7.3.12.4. Strategic initiatives
                          7.3.13. AGC BiologicsL
                              7.3.13.1. Company overview
                              7.3.13.2. Financial performance
                              7.3.13.3. Product benchmarking
                              7.3.13.4. Strategic initiatives
                          7.3.14. Thermo Fisher
                              7.3.14.1. Company overview
                              7.3.14.2. Financial performance
                              7.3.14.3. Product benchmarking
                              7.3.14.4. Strategic initiatives
                          7.3.15. Scientific Inc.
                              7.3.15.1. Company overview
                              7.3.15.2. Financial performance
                              7.3.15.3. Product benchmarking
                              7.3.15.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Cell Banking Outsourcing Market, By Type, 2018 - 2030 (USD Billion)
Table 3. U.S. Cell Banking Outsourcing Market, By Cell Type, 2018 - 2030 (USD Billion)
Table 4. U.S. Cell Banking Outsourcing , By Phase, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Cell Banking Outsourcing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Cell Banking Outsourcing Market: Cell Type outlook and key takeaways
Fig. 15 Cell Banking Outsourcing Market: Cell Type Movement Analysis & market share 2023 & 2030
Fig. 16 Master cell banking market, 2018 - 2030 (USD Million)
Fig. 17 Working cell banking market, 2018 - 2030 (USD Million)
Fig. 18 Viral cell banking market, 2018 - 2030 (USD Million)
Fig. 19 stem cells market, for stem cells, 2018 - 2030 (USD Million)
Fig. 20 Cord cell banking market, 2018 - 2030 (USD Million)
Fig. 21 Embryonic stem cell market, 2018 - 2030 (USD Million)
Fig. 22 adult stem cell banking market, 2018 - 2030 (USD Million)
Fig. 23 Dental stem cell banking market, 2018 - 2030 (USD Million)
Fig. 24 IPS stem cell banking market, 2018 - 2030 (USD Million)g. 22
Fig. 25 Cell Banking Outsourcing Market Phase outlook and key takeaways
Fig. 26 Cell Banking Outsourcing Market: Phase movement analysis & market share 2023 & 2030
Fig. 27 Bank storage market, 2018 - 2030 (USD Million)
Fig. 28 Master cell bank prep market, 2018 - 2030 (USD Million)
Fig. 29 Working cell bank prep market, 2018 - 2030 (USD Million)
Fig. 30 Cell storage stability testing market, 2018 - 2030 (USD Million)
Fig. 31 Bank characterization & testing market, 2018 - 2030 (USD Million)
Fig. 32 Safety testing market, 2018 - 2030 (USD Million)
Fig. 33 Viral cell banks market, 2018 - 2030 (USD Million)
Fig. 34 Gene expression testing market, 2018 - 2030 (USD Million)
Fig. 35 Karyology testing market, 2018 - 2030 (USD Million)
Fig. 36 Gene sequencing testing market, 2018 - 2030 (USD Million)
Fig. 37 Bank preparation market, 2018 - 2030 (USD Million)
Fig. 38 Master cell bank prep market, 2018 - 2030 (USD Million)
Fig. 39 Working cell bank prep market, 2018 - 2030 (USD Million)